This article has Open Peer Review reports available.
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1
© Liu et al.; licensee BioMed Central Ltd. 2012
Received: 4 July 2012
Accepted: 12 November 2012
Published: 14 November 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|4 Jul 2012||Submitted||Original manuscript|
|6 Jul 2012||Author responded||Author comments - Zhao-Xia Wang|
|Resubmission - Version 2|
|6 Jul 2012||Submitted||Manuscript version 2|
|23 Sep 2012||Reviewed||Reviewer Report - Olivier Pardo|
|1 Oct 2012||Reviewed||Reviewer Report - Klaus Strebhardt|
|16 Oct 2012||Author responded||Author comments - Zhao-Xia Wang|
|Resubmission - Version 3|
|16 Oct 2012||Submitted||Manuscript version 3|
|24 Oct 2012||Reviewed||Reviewer Report - Klaus Strebhardt|
|6 Nov 2012||Author responded||Author comments - Zhao-Xia Wang|
|Resubmission - Version 4|
|6 Nov 2012||Submitted||Manuscript version 4|
|12 Nov 2012||Editorially accepted|
|14 Nov 2012||Article published||10.1186/1471-2407-12-519|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.